{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:09:06Z","timestamp":1787314146566,"version":"build-2736575974"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Compound heterozygous recessive or polygenic diseases could be addressed through gene correction of multiple alleles. However, targeting of multiple alleles using genome editors could lead to mixed genotypes and adverse events that amplify during tissue morphogenesis. Here we demonstrate that Cas9-ribonucleoprotein-based genome editors can correct two distinct mutant alleles within a single human cell precisely. Gene-corrected cells in an induced pluripotent stem cell model of Pompe disease expressed the corrected transcript from both corrected alleles, leading to enzymatic cross-correction of diseased cells. Using a quantitative in silico model for the in vivo delivery of genome editors into the developing human infant liver, we identify progenitor targeting, delivery efficiencies, and suppression of imprecise editing outcomes at the on-target site as key design parameters\u00a0that control the efficacy of various therapeutic strategies. This work establishes that precise gene editing to correct multiple distinct gene variants could be highly efficacious if designed appropriately.<\/jats:p>","DOI":"10.1038\/s41467-020-20065-8","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T06:29:58Z","timestamp":1607408998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseases"],"prefix":"10.1038","volume":"11","author":[{"given":"Jared","family":"Carlson-Stevermer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amritava","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr A.","family":"Abdeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fiflis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin I","family":"Grindel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugce","family":"Akcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tausif","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Kletzien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucille","family":"Kohlenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Goedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah J.","family":"Dombroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-0858","authenticated-orcid":false,"given":"Krishanu","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"key":"20065_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DBT Cox","year":"2015","unstructured":"Cox, D. B. T., Platt, R. J. & Zhang, F. Therapeutic genome editing: prospects and challenges. Nat. Med. 21, 121\u2013131 (2015).","journal-title":"Nat. Med."},{"key":"20065_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fnagi.2014.00177","volume":"6","author":"J-A Lim","year":"2014","unstructured":"Lim, J.-A., Li, L. & Raben, N. Pompe disease: from pathophysiology to therapy and back again. Front. Aging Neurosci. 6, 177 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"20065_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrd.2016.280","volume":"16","author":"H Yin","year":"2017","unstructured":"Yin, H., Kauffman, K. J. & Anderson, D. G. Delivery technologies for genome editing. Nat. Rev. Drug Discov. 16, 387\u2013399 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"20065_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.tibtech.2018.08.010","volume":"37","author":"Y Rui","year":"2019","unstructured":"Rui, Y., Wilson, D. R. & Green, J. J. Non-viral delivery to enable genome editing. Trends Biotechnol. 37, 281\u2013293 (2019).","journal-title":"Trends Biotechnol."},{"key":"20065_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nchembio.1793","volume":"11","author":"KM Davis","year":"2015","unstructured":"Davis, K. M., Pattanayak, V., Thompson, D. B., Zuris, J. A. & Liu, D. R. Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat. Chem. Biol. 11, 316\u2013318 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"20065_CR6","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1021\/ja512664v","volume":"137","author":"J Hemphill","year":"2015","unstructured":"Hemphill, J., Borchardt, E. K., Brown, K., Asokan, A. & Deiters, A. Optical Control of CRISPR\/Cas9 Gene Editing. J. Am. Chem. Soc. 137, 5642\u20135645 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"20065_CR7","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Double Nicking by RNA-Guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380\u20131389 (2013).","journal-title":"Cell"},{"key":"20065_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P. et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523, 481\u2013485 (2015).","journal-title":"Nature"},{"key":"20065_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver, B. P. et al. High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490\u2013495 (2016).","journal-title":"Nature"},{"key":"20065_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aad5227","volume":"351","author":"IM Slaymaker","year":"2015","unstructured":"Slaymaker, I. M. et al. Rationally engineered Cas9 nucleases with improved specificity. Science 351, 84\u201388 (2015).","journal-title":"Science"},{"key":"20065_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nbt.3198","volume":"33","author":"VT Chu","year":"2015","unstructured":"Chu, V. T. et al. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat. Biotechnol. 33, 543\u2013548 (2015).","journal-title":"Nat. Biotechnol."},{"key":"20065_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.stem.2015.01.003","volume":"16","author":"C Yu","year":"2015","unstructured":"Yu, C. et al. Small molecules enhance CRISPR genome editing in pluripotent stem cells. Cell Stem Cell 16, 142\u2013147 (2015).","journal-title":"Cell Stem Cell"},{"key":"20065_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/srep21264","volume":"6","author":"D Yang","year":"2016","unstructured":"Yang, D. et al. Enrichment of G2\/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases. Sci. Rep. 6, 21264 (2016).","journal-title":"Sci. Rep."},{"key":"20065_CR14","doi-asserted-by":"publisher","first-page":"e04766","DOI":"10.7554\/eLife.04766","volume":"3","author":"S Lin","year":"2014","unstructured":"Lin, S., Staahl, B. T., Alla, R. K. & Doudna, J. A. Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery. eLife 3, e04766 (2014).","journal-title":"eLife"},{"key":"20065_CR15","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.celrep.2016.01.019","volume":"14","author":"T Gutschner","year":"2016","unstructured":"Gutschner, T., Haemmerle, M., Genovese, G., Draetta, G. F. & Chin, L. Post-translational regulation of Cas9 during G1 enhances homology-directed repair. Cell Rep. 14, 1555\u20131566 (2016).","journal-title":"Cell Rep."},{"key":"20065_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nbt.3481","volume":"34","author":"CD Richardson","year":"2016","unstructured":"Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L. & Corn, J. E. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA. Nat. Biotechnol. 34, 339\u2013344 (2016).","journal-title":"Nat. Biotechnol."},{"key":"20065_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jbiotec.2016.11.011","volume":"241","author":"X Liang","year":"2017","unstructured":"Liang, X., Potter, J., Kumar, S., Ravinder, N. & Chesnut, J. D. Enhanced CRISPR\/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA. J. Biotechnol. 241, 136\u2013146 (2017).","journal-title":"J. Biotechnol."},{"key":"20065_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/mt.2016.5","volume":"24","author":"V Prakash","year":"2016","unstructured":"Prakash, V., Moore, M. & Y\u00e1\u00f1ez-Mu\u00f1oz, R. J. Current progress in therapeutic gene editing for monogenic diseases. Mol. Ther. 24, 465\u2013474 (2016).","journal-title":"Mol. Ther."},{"key":"20065_CR19","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.celrep.2015.07.062","volume":"12","author":"AL Firth","year":"2015","unstructured":"Firth, A. L. et al. Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs. Cell Rep. 12, 1385\u20131390 (2015).","journal-title":"Cell Rep"},{"key":"20065_CR20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/mt.2014.234","volume":"23","author":"DG Ousterout","year":"2015","unstructured":"Ousterout, D. G. et al. Correction of dystrophin expression in cells from duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases. Mol. Ther. 23, 523\u2013532 (2015).","journal-title":"Mol. Ther"},{"key":"20065_CR21","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1056\/NEJMoa1609677","volume":"376","author":"J-A Ribeil","year":"2017","unstructured":"Ribeil, J.-A. et al. Gene therapy in a patient with sickle cell disease. N. Engl. J. Med. 376, 848\u2013855 (2017).","journal-title":"N. Engl. J. Med"},{"key":"20065_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature10177","volume":"475","author":"H Li","year":"2011","unstructured":"Li, H. et al. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475, 217\u2013221 (2011).","journal-title":"Nature"},{"key":"20065_CR23","doi-asserted-by":"publisher","first-page":"eaah3480","DOI":"10.1126\/scitranslmed.aah3480","volume":"9","author":"SSD Ravin","year":"2017","unstructured":"Ravin, S. S. D. et al. CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease. Sci. Transl. Med. 9, eaah3480\u2013eaah3480 (2017).","journal-title":"Sci. Transl. Med."},{"key":"20065_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","volume":"25","author":"ML Maeder","year":"2019","unstructured":"Maeder, M. L. et al. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nat. Med. 25, 229\u2013233 (2019).","journal-title":"Nat. Med."},{"key":"20065_CR25","unstructured":"Stadtmauer, E. A. et al. CRISPR-engineered T cells in patients with refractory cancer. Science 367, eaba7365 (2020)."},{"key":"20065_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson, C. E. et al. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat. Med. 25, 427\u2013432 (2019).","journal-title":"Nat. Med."},{"key":"20065_CR27","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.stemcr.2017.12.004","volume":"10","author":"B Steyer","year":"2018","unstructured":"Steyer, B. et al. Scarless genome editing of human pluripotent stem cells via transient puromycin selection. Stem Cell Rep. 10, 642\u2013654 (2018).","journal-title":"Stem Cell Rep."},{"key":"20065_CR28","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","volume":"144","author":"PS Kishnani","year":"2004","unstructured":"Kishnani, P. S. & Howell, R. R. Pompe disease in infants and children. J. Pediatr. 144, S35\u2013S43 (2004).","journal-title":"J. Pediatr."},{"key":"20065_CR29","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1542\/peds.2016-0280C","volume":"140","author":"OA Bodamer","year":"2017","unstructured":"Bodamer, O. A., Scott, C. R. & Giugliani, R., Group, on behalf of the P. D. N. S. W. Newborn screening for Pompe disease. Pediatrics 140, S4\u2013S13 (2017).","journal-title":"Pediatrics"},{"key":"20065_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.omtm.2016.12.010","volume":"4","author":"S Han","year":"2017","unstructured":"Han, S. et al. Low-dose liver-targeted gene therapy for Pompe disease enhances therapeutic efficacy of ert via immune tolerance induction. Mol. Ther. Methods Clin. Dev. 4, 126\u2013136 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"20065_CR31","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1093\/hmg\/11.14.1637","volume":"11","author":"E Martin-Touaux","year":"2002","unstructured":"Martin-Touaux, E. et al. Muscle as a putative producer of acid \u03b1-glucosidase for glycogenosis type II gene therapy. Hum. Mol. Genet 11, 1637\u20131645 (2002).","journal-title":"Hum. Mol. Genet"},{"key":"20065_CR32","doi-asserted-by":"crossref","unstructured":"Ding, E. Y. et al. Long-term efficacy after [E1-, polymerase-] adenovirus-mediated transfer of human acid-\u03b1-glucosidase gene into glycogen storage disease type II knockout mice. Hum. Gene Ther. 12, 955\u2013965 (2001).","DOI":"10.1089\/104303401750195917"},{"key":"20065_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jgm.660","volume":"7","author":"F Xu","year":"2005","unstructured":"Xu, F. et al. Glycogen storage in multiple muscles of old GSD-II mice can be rapidly cleared after a single intravenous injection with a modified adenoviral vector expressing hGAA. J. Gene Med. 7, 171\u2013178 (2005).","journal-title":"J. Gene Med."},{"key":"20065_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.omtn.2017.03.001","volume":"7","author":"E van der Wal","year":"2017","unstructured":"van der Wal, E., Bergsma, A. J., Pijnenburg, J. M., van der Ploeg, A. T. & Pijnappel, W. W. M. P. Antisense oligonucleotides promote exon inclusion and correct the common c.-32-13T>G GAA splicing variant in pompe disease. Mol. Ther. Nucleic Acids 7, 90\u2013100 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"20065_CR35","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.stemcr.2018.04.002","volume":"10","author":"E van der Wal","year":"2018","unstructured":"van der Wal, E. et al. Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies. Stem Cell Rep. 10, 1975\u20131990 (2018).","journal-title":"Stem Cell Rep."},{"key":"20065_CR36","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.stem.2015.12.002","volume":"18","author":"WT Hendriks","year":"2016","unstructured":"Hendriks, W. T., Warren, C. R. & Cowan, C. A. Genome editing in human pluripotent stem cells: approaches, pitfalls, and solutions. Cell Stem Cell 18, 53\u201365 (2016).","journal-title":"Cell Stem Cell"},{"key":"20065_CR37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.stem.2017.01.010","volume":"20","author":"CR Warren","year":"2017","unstructured":"Warren, C. R. et al. Induced pluripotent stem cell differentiation enables functional validation of GWAS variants in metabolic disease. Cell Stem Cell 20, 547\u2013557.e7 (2017).","journal-title":"Cell Stem Cell"},{"key":"20065_CR38","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.stem.2009.11.009","volume":"5","author":"K Saha","year":"2009","unstructured":"Saha, K. & Jaenisch, R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5, 584\u2013595 (2009).","journal-title":"Cell Stem Cell"},{"key":"20065_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrcardio.2016.36","volume":"13","author":"IY Chen","year":"2016","unstructured":"Chen, I. Y., Matsa, E. & Wu, J. C. Induced pluripotent stem cells: at the heart of cardiovascular precision medicine. Nat. Rev. Cardiol. 13, 333\u2013349 (2016).","journal-title":"Nat. Rev. Cardiol."},{"key":"20065_CR40","doi-asserted-by":"crossref","unstructured":"Torii, R., Velliou, R.-I., Hodgson, D. & Mudera, V. Modelling multi-scale cell\u2013tissue interaction of tissue-engineered muscle constructs. J. Tissue Eng. 9, 2041731418787141 (2018).","DOI":"10.1177\/2041731418787141"},{"key":"20065_CR41","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/01.TP.0000130177.03326.D5","volume":"78","author":"S Matsumoto","year":"2004","unstructured":"Matsumoto, S., Tanaka, K., Strong, D. M. & Reems, J. A. Efficacy of human islet isolation from the tail section of the pancreas for the possibility of living donor islet transplantation. Transplantation 78, 839\u2013843 (2004).","journal-title":"Transplantation"},{"key":"20065_CR42","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(05)66383-0","volume":"365","author":"S Matsumoto","year":"2005","unstructured":"Matsumoto, S. et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 365, 1642\u20131644 (2005).","journal-title":"Lancet"},{"key":"20065_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science 368, 290\u2013296 (2020).","journal-title":"Science"},{"key":"20065_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149\u2013157 (2019).","journal-title":"Nature"},{"key":"20065_CR45","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/nbt.4194","volume":"36","author":"MP Zafra","year":"2018","unstructured":"Zafra, M. P. et al. Optimized base editors enable efficient editing in cells, organoids and mice. Nat. Biotechnol. 36, 888\u2013893 (2018).","journal-title":"Nat. Biotechnol."},{"key":"20065_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41551-019-0357-8","volume":"4","author":"C-Q Song","year":"2019","unstructured":"Song, C.-Q. et al. Adenine base editing in an adult mouse model of tyrosinaemia. Nat. Biomed. Eng. 4, 125\u2013130 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"20065_CR47","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1074\/jbc.M114.628628","volume":"290","author":"KK Raval","year":"2015","unstructured":"Raval, K. K. et al. Pompe disease results in a golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes. J. Biol. Chem. 290, 3121\u20133136 (2015).","journal-title":"J. Biol. Chem."},{"key":"20065_CR48","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.2673","volume":"31","author":"V Pattanayak","year":"2013","unstructured":"Pattanayak, V. et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 31, 839\u2013843 (2013).","journal-title":"Nat. Biotechnol."},{"key":"20065_CR49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.stemcr.2015.11.014","volume":"6","author":"J Carlson-Stevermer","year":"2016","unstructured":"Carlson-Stevermer, J. et al. High-content analysis of CRISPR-Cas9 gene-edited human embryonic stem cells. Stem Cell Rep. 6, 109\u2013120 (2016).","journal-title":"Stem Cell Rep."},{"key":"20065_CR50","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol"},{"key":"20065_CR51","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.cell.2016.05.053","volume":"165","author":"MW Popp","year":"2016","unstructured":"Popp, M. W. & Maquat, L. E. Leveraging rules of nonsense-mediated mRNA decay for genome engineering and personalized medicine. Cell 165, 1319\u20131322 (2016).","journal-title":"Cell"},{"key":"20065_CR52","doi-asserted-by":"crossref","unstructured":"El-Brolosy, M. A. & Stainier, D. Y. R. Genetic compensation: A phenomenon in search of mechanisms. PLoS Genet. 13, e1006780 (2017).","DOI":"10.1371\/journal.pgen.1006780"},{"key":"20065_CR53","doi-asserted-by":"crossref","unstructured":"Migani, D., Smales, C. M. & Bracewell, D. G. Effects of lysosomal biotherapeutic recombinant protein expression on cell stress and protease and general host cell protein release in Chinese hamster ovary cells. Biotechnol. Prog. 33, 666\u2013676 (2017).","DOI":"10.1002\/btpr.2455"},{"key":"20065_CR54","doi-asserted-by":"publisher","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","volume":"109","author":"X Lian","year":"2012","unstructured":"Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl Acad. Sci 109, E1848\u2013E1857 (2012).","journal-title":"Proc. Natl Acad. Sci"},{"key":"20065_CR55","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1203\/00006450-199803000-00011","volume":"43","author":"HW Yang","year":"1998","unstructured":"Yang, H. W. et al. Recombinant human acid \u03b1-glucosidase Corrects Acid\u03b1-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts. Pediatr. Res. 43, 374\u2013380 (1998).","journal-title":"Pediatr. Res."},{"key":"20065_CR56","doi-asserted-by":"crossref","unstructured":"Ma, L., Ouyang, Q., Werthmann, G. C., Thompson, H. M. & Morrow, E. M. Live-cell microscopy and fluorescence-based measurement of luminal pH in intracellular organelles. Front. Cell Dev. Biol. 5, 71 (2017).","DOI":"10.3389\/fcell.2017.00071"},{"key":"20065_CR57","doi-asserted-by":"publisher","first-page":"103737","DOI":"10.1016\/j.cellimm.2017.12.011","volume":"342","author":"JE Bond","year":"2019","unstructured":"Bond, J. E., Kishnani, P. S. & Koeberl, D. D. Immunomodulatory, liver depot gene therapy for Pompe disease. Cell. Immunol. 342, 103737 (2019).","journal-title":"Cell. Immunol."},{"key":"20065_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani, P. S. et al. Recombinant human acid \u03b1-glucosidase major clinical benefits in infantile-onset Pompe disease. Neurology 68, 99\u2013109 (2007).","journal-title":"Neurology"},{"key":"20065_CR59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","volume":"80","author":"N Raben","year":"2003","unstructured":"Raben, N. et al. Enzyme replacement therapy in the mouse model of Pompe disease. Mol. Genet. Metab. 80, 159\u2013169 (2003).","journal-title":"Mol. Genet. Metab."},{"key":"20065_CR60","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature14863","volume":"524","author":"B Wang","year":"2015","unstructured":"Wang, B., Zhao, L., Fish, M., Logan, C. Y. & Nusse, R. Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver. Nature 524, 180\u2013185 (2015).","journal-title":"Nature"},{"key":"20065_CR61","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nbt.2884","volume":"32","author":"H Yin","year":"2014","unstructured":"Yin, H. et al. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32, 551\u2013553 (2014).","journal-title":"Nat. Biotechnol."},{"key":"20065_CR62","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nbt.3469","volume":"34","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice. Nat. Biotechnol. 34, 334\u2013338 (2016).","journal-title":"Nat. Biotechnol."},{"key":"20065_CR63","doi-asserted-by":"crossref","unstructured":"Yin, H. et al. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat. Biotechnol. 34, 328\u2013333 (2016).","DOI":"10.1038\/nbt.3471"},{"key":"20065_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17029-3","volume":"11","author":"T Wei","year":"2020","unstructured":"Wei, T., Cheng, Q., Min, Y.-L., Olson, E. N. & Siegwart, D. J. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing. Nat. Commun. 11, 3232 (2020).","journal-title":"Nat. Commun."},{"key":"20065_CR65","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbrc.2018.05.130","volume":"502","author":"JH Shin","year":"2018","unstructured":"Shin, J. H., Jung, S., Ramakrishna, S., Kim, H. H. & Lee, J. In vivo gene correction with targeted sequence substitution through microhomology-mediated end joining. Biochem. Biophys. Res. Commun. 502, 116\u2013122 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"20065_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1515-0","volume":"19","author":"R Ibraheim","year":"2018","unstructured":"Ibraheim, R. et al. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo. Genome Biol. 19, 137 (2018).","journal-title":"Genome Biol."},{"key":"20065_CR67","doi-asserted-by":"publisher","first-page":"E9944","DOI":"10.1073\/pnas.1811276115","volume":"115","author":"CD Sago","year":"2018","unstructured":"Sago, C. D. et al. High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing. Proc. Natl Acad. Sci. USA 115, E9944\u2013E9952 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"20065_CR68","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-018-0209-1","volume":"24","author":"L Villiger","year":"2018","unstructured":"Villiger, L. et al. Treatment of a metabolic liver disease by in vivo genome base editing in adult mice. Nat. Med. 24, 1519\u20131525 (2018).","journal-title":"Nat. Med."},{"key":"20065_CR69","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.molcel.2016.02.030","volume":"61","author":"C Albayrak","year":"2016","unstructured":"Albayrak, C. et al. Digital quantification of proteins and mRNA in single mammalian cells. Mol. Cell 61, 914\u2013924 (2016).","journal-title":"Mol. Cell"},{"key":"20065_CR70","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nbt1326","volume":"25","author":"H Azuma","year":"2007","unstructured":"Azuma, H. et al. Robust expansion of human hepatocytes in Fah\u2212\/\u2212\/Rag2\u2212\/\u2212\/Il2rg \u2212\/\u2212 mice. Nat. Biotechnol. 25, 903\u2013910 (2007).","journal-title":"Nat. Biotechnol."},{"key":"20065_CR71","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nmeth.3414","volume":"12","author":"A Kulesa","year":"2015","unstructured":"Kulesa, A., Krzywinski, M., Blainey, P. & Altman, N. Sampling distributions and the bootstrap. Nat. Methods 12, 477\u2013478 (2015).","journal-title":"Nat. Methods"},{"key":"20065_CR72","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41586-018-0686-x","volume":"563","author":"MW Shen","year":"2018","unstructured":"Shen, M. W. et al. Predictable and precise template-free CRISPR editing of pathogenic variants. Nature 563, 646 (2018).","journal-title":"Nature"},{"key":"20065_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01408-4","volume":"8","author":"LB Harrington","year":"2017","unstructured":"Harrington, L. B. et al. A thermostable Cas9 with increased lifetime in human plasma. Nat. Commun. 8, 1424 (2017).","journal-title":"Nat. Commun."},{"key":"20065_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01875-9","volume":"8","author":"J Carlson-Stevermer","year":"2017","unstructured":"Carlson-Stevermer, J. et al. Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing. Nat. Commun. 8, 1711 (2017).","journal-title":"Nat. Commun."},{"key":"20065_CR75","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.ymthe.2017.02.017","volume":"25","author":"P Kishnani","year":"2017","unstructured":"Kishnani, P. et al. Duvoglustat HCl increases systemic and tissue exposure of active acid \u03b1-glucosidase in pompe patients co-administered with alglucosidase \u03b1. Mol. Ther. 25, 1199\u20131208 (2017).","journal-title":"Mol. Ther."},{"key":"20065_CR76","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T. et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat. Med. 25, 249\u2013254 (2019).","journal-title":"Nat. Med"},{"key":"20065_CR77","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","volume":"10","author":"VL Simhadri","year":"2018","unstructured":"Simhadri, V. L. et al. Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population. Mol. Ther. Methods Clin. Dev. 10, 105\u2013112 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"20065_CR78","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nmeth.3993","volume":"13","author":"WL Chew","year":"2016","unstructured":"Chew, W. L. et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat. Methods 13, 868\u2013874 (2016).","journal-title":"Nat. Methods"},{"key":"20065_CR79","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","volume":"25","author":"DL Wagner","year":"2019","unstructured":"Wagner, D. L. et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat. Med. 25, 242 (2019).","journal-title":"Nat. Med."},{"key":"20065_CR80","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1128\/CVI.00262-10","volume":"17","author":"JW Youm","year":"2010","unstructured":"Youm, J. W. et al. Antibody responses in mice stimulated by various doses of the potato-derived major surface antigen of hepatitis B virus. Clin. Vaccin. Immunol. 17, 2029\u20132032 (2010).","journal-title":"Clin. Vaccin. Immunol."},{"key":"20065_CR81","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijpharm.2005.05.028","volume":"301","author":"YK Katare","year":"2005","unstructured":"Katare, Y. K., Muthukumaran, T. & Panda, A. K. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles. Int. J. Pharm. 301, 149\u2013160 (2005).","journal-title":"Int. J. Pharm."},{"key":"20065_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1128\/MMBR.64.1.51-68.2000","volume":"64","author":"C Seeger","year":"2000","unstructured":"Seeger, C. & Mason, W. S. Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64, 51\u201368 (2000).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"20065_CR83","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.scr.2018.01.009","volume":"27","author":"TT Duong","year":"2018","unstructured":"Duong, T. T. et al. Use of induced pluripotent stem cell models to probe the pathogenesis of Choroideremia and to develop a potential treatment. Stem Cell Res. 27, 140\u2013150 (2018).","journal-title":"Stem Cell Res."},{"key":"20065_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26481-7","volume":"8","author":"S Torriano","year":"2018","unstructured":"Torriano, S. et al. The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy. Sci. Rep. 8, 8234 (2018).","journal-title":"Sci. Rep."},{"key":"20065_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-35","volume":"7","author":"A Herzog","year":"2012","unstructured":"Herzog, A. et al. A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations. Orphanet J. Rare Dis. 7, 35 (2012).","journal-title":"Orphanet J. Rare Dis."},{"key":"20065_CR86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymgmr.2017.10.009","volume":"14","author":"Y Fukuhara","year":"2018","unstructured":"Fukuhara, Y. et al. A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan. Mol. Genet. Metab. Rep. 14, 3\u20139 (2018).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"20065_CR87","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"20065_CR88","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41576-018-0077-z","volume":"20","author":"R Cloney","year":"2019","unstructured":"Cloney, R. The oracle of inDelphi predicts Cas9 repair outcomes. Nat. Rev. Genet. 20, 4 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"20065_CR89","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nbt.4317","volume":"37","author":"F Allen","year":"2018","unstructured":"Allen, F. et al. Predicting the mutations generated by repair of Cas9-induced double-strand breaks. Nat. Biotechnol. 37, 64\u201372 (2018).","journal-title":"Nat. Biotechnol"},{"key":"20065_CR90","doi-asserted-by":"crossref","unstructured":"Ronzitti, G., Collaud, F., Laforet, P. & Mingozzi, F. Progress and challenges of gene therapy for Pompe disease. Ann. Transl. Med. 7, 287 (2019).","DOI":"10.21037\/atm.2019.04.67"},{"key":"20065_CR91","doi-asserted-by":"crossref","unstructured":"Sendra, L., Herrero, M. J. & Ali\u00f1o, S. F. Translational advances of hydrofection by hydrodynamic injection. Genes 9, 136 (2018).","DOI":"10.3390\/genes9030136"},{"key":"20065_CR92","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","volume":"28","author":"A Li","year":"2020","unstructured":"Li, A. et al. AAV-CRISPR Gene editing is negated by pre-existing immunity to Cas9. Mol. Ther. 28, 1432\u20131441 (2020).","journal-title":"Mol. Ther"},{"key":"20065_CR93","doi-asserted-by":"publisher","unstructured":"Haapaniemi, E., Botla, S., Persson, J., Schmierer, B. & Taipale, J. CRISPR\u2013Cas9 genome editing induces a p53-mediated DNA damage response. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-018-0049-z (2018).","DOI":"10.1038\/s41591-018-0049-z"},{"key":"20065_CR94","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.ymthe.2018.06.002","volume":"26","author":"MK Cromer","year":"2018","unstructured":"Cromer, M. K. et al. Global Transcriptional Response to CRISPR\/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells. Mol. Ther. 26, 2431\u20132442 (2018).","journal-title":"Mol. Ther."},{"key":"20065_CR95","doi-asserted-by":"crossref","unstructured":"Sinha, D. et al. Human iPSC modeling reveals mutation-specific responses to gene therapy in a genotypically diverse dominant maculopathy. Am. J. Hum. Genet. 107, 278\u2013292 (2020).","DOI":"10.1016\/j.ajhg.2020.06.011"},{"key":"20065_CR96","unstructured":"Temple, A. Somatic Cell Gene Editing. Somatic Cell Gene Editing https:\/\/scge.mcw.edu\/."},{"key":"20065_CR97","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1056\/NEJMoa1910607","volume":"382","author":"E Liu","year":"2020","unstructured":"Liu, E. et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. N. Engl. J. Med. 382, 545\u2013553 (2020).","journal-title":"N. Engl. J. Med."},{"key":"20065_CR98","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41551-018-0318-7","volume":"3","author":"H Zhu","year":"2019","unstructured":"Zhu, H. et al. Spatial control of in vivo CRISPR\u2013Cas9 genome editing via nanomagnets. Nat. Biomed. Eng. 3, 126 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"20065_CR99","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41551-018-0252-8","volume":"2","author":"B Lee","year":"2018","unstructured":"Lee, B. et al. Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours. Nat. Biomed. Eng. 2, 497 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"20065_CR100","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/biot.201400756","volume":"10","author":"T Harkness","year":"2015","unstructured":"Harkness, T. et al. High-content imaging with micropatterned multiwell plates reveals influence of cell geometry and cytoskeleton on chromatin dynamics. Biotechnol. J. 10, 1555\u20131567 (2015).","journal-title":"Biotechnol. J."},{"key":"20065_CR101","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1021\/bm400900r","volume":"14","author":"J Sha","year":"2013","unstructured":"Sha, J., Lippmann, E. S., McNulty, J., Ma, Y. & Ashton, R. S. Sequential nucleophilic substitutions permit orthogonal click functionalization of multicomponent PEG brushes. Biomacromolecules 14, 3294\u20133303 (2013).","journal-title":"Biomacromolecules"},{"key":"20065_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).","journal-title":"Genome Biol."},{"key":"20065_CR103","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"F Ran","year":"2013","unstructured":"Ran, F. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"20065_CR104","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q. et al. GUIDE-Seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2015).","journal-title":"Nat. Biotechnol."},{"key":"20065_CR105","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bioinformatics\/btw561","volume":"33","author":"J Park","year":"2017","unstructured":"Park, J., Lim, K., Kim, J.-S. & Bae, S. Cas-analyzer: an online tool for assessing genome editing results using NGS data. Bioinformatics 33, 286\u2013288 (2017).","journal-title":"Bioinformatics"},{"key":"20065_CR106","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/bioinformatics\/btl485","volume":"22","author":"S Hoops","year":"2006","unstructured":"Hoops, S. et al. COPASI\u2013a COmplex PAthway SImulator. Bioinforma. Oxf. Engl. 22, 3067\u20133074 (2006).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"20065_CR107","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.clinbiochem.2017.09.008","volume":"50","author":"M Cui","year":"2017","unstructured":"Cui, M. et al. Combining Nordtest method and bootstrap resampling for measurement uncertainty estimation of hematology analytes in a medical laboratory. Clin. Biochem. 50, 1067\u20131072 (2017).","journal-title":"Clin. Biochem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20065-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20065-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20065-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T21:16:29Z","timestamp":1670274989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20065-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":107,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["20065"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-20065-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,8]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C.-S., A.A., L.K., and K.S. have filed a patent application on the S1mplex technology. Patent Applicant: Institution - WISCONSIN ALUMNI RESEARCH FOUNDATION (MADISON, WI, US) Name of Inventors: Carlson-stevermer, Jared Matthew (Madison, WI, US) Saha, Krishanu (Middleton, WI, US) Abdeen, Amr Ashraf (Madison, WI, US) Kohlenberg, Lucille Katherine (Madison, WI, US) Application number: United States Patent Application 20180362971 Status of Application: Filed Aspect of Manuscript: Generation of single edited clones, and double-edited clones c1, c28, c29, and c30. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6277"}}